Healthcare Webinars

We believe digital is now a wider determinant of health. As well as shaping access to health and care services, digital impacts across all aspects of our lives, affecting our opportunities and shaping health inequalities. Digital technologies and online services can improve health and wellbeing – as long as people have the access, skills, confidence and support to benefit. Join us for a three part seminar series, where you will hear from a range of VCSE Health and Wellbeing Alliance members, sharing learnings, case studies and examples of best practice for designing for digital inclusion in healthcare.

Cryopreservation, a cornerstone in the field of cell therapy, is the process of preserving biological source materials at ultra-low temperatures to maintain their viability and functionality for future therapeutic applications. In this webinar, industry experts will share their experience on the critical importance of cryopreservation, discussing considerations such as processing requirements, buffer composition, controlled rate freezing, and cold chain logistics. Join this webinar to learn about cryopreservation, a vital step in the manufacturing of today’s cell and gene therapies.

The challenge of running successful global trials is highly demanding and has become increasingly costly. Sourcing commercially available medications for these trials can be both complex and resource-intensive. This webinar will introduce innovative sourcing strategies for commercially available medications while assessing the pros and cons of the different options. The speaker will provide insight into key considerations when choosing the appropriate sourcing option(s) and discuss the value of migrating from a transactional approach to strategic sourcing.

Attend this webinar to learn more about Percutaneous leaflet repair and replacement, tricuspid regurgitation, Tricuspid TEER, also known as edge-to-edge repair, and percutaneous tricuspid valve replacement, the new treatment options for patients with severe tricuspid regurgitation. Join this webinar if you want to further understand the pathophysiology of TR, or need guidance on clinical and imaging selection of patients who might be suitable for treatment. This webinar is aimed at all clinicians involved in the management of patients with tricuspid regurgitation.

Sponsored by MGRI Division of Clinical Research and Harvard Center for Bioethics Title: Ethical Considerations of Access to Investigational Medicines Speaker: Karla G. Childers, BA, MSJ, MSBE, Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer, Johnson & Johnson

Sarcoma Foundation of America is dedicated to fostering the development of innovative treatment options for those affected by sarcoma. In collaboration with the esteemed CDRC Sarcoma Task Force, we are excited to present a pioneering project that delves into the potential of repurposing existing medications for the benefit of sarcoma patients. This initiative is at the forefront of leveraging real-world data—from electronic medical records to invaluable insights shared by patients and their healthcare providers. The goal is to illuminate the path to cost-effective treatments, harnessing the power of existing drugs that, while proven safe, require further evidence to support their novel application in sarcoma therapy. Your involvement is crucial in propelling this research forward, paving the way for new, accessible treatment avenues for the sarcoma community.

The evolving landscape of immune-oncology and cancer therapy research is being profoundly reshaped by single-cell RNA sequencing technologies. Join this webinar to discover the significance of single-cell omics profiling in oncological research, unraveling tumor microenvironment complexities post-immune therapies using single-cell RNA sequencing, and detailed analysis of transcriptional changes in specific cell types under various conditions.

Discover an informative webinar delving into DNA-encoded library (DEL) technology in drug discovery, showcasing tailored campaigns, parallel screening and innovative hit identification for challenging targets.

Asim Shabbir: “How and why lowering of BMI thresholds and a move from BMI to clinical indications matters in the APC” Mark Magdy: “The impact of medications (as alternatives and adjuncts to surgery) and expected uptake in APC” Ahmad Aly: “What the global congress coming to the APC in 2024 can offer and a preview”

The COVID-19 pandemic prompted a rapid shift towards digital health solutions to address healthcare challenges, offering virtual access to a range of services including contact tracing, public health updates, virtual care, mental health support, and vaccine booking. While digital technologies helped mitigate virus spread, their unintended impact on health equity, particularly for marginalized racialized low-income communities, emerged as a parallel concern. This research investigates the influence of digital health adoption on pre-existing inequities among racialized Ontarians, utilizing a qualitative literature review. The study examines healthcare structures, socio-economic factors, and assesses the 2019 Digital First for Health Strategy's impact on health equity. COVID-19 policies and digital tools are analyzed for their effect on racialized populations, revealing existing gaps. Despite public funding, Ontario's healthcare system remains unequal, disproportionately affecting racialized communities during the pandemic due to discriminatory policies and inaccessible digital solutions. Pre-pandemic analysis confirms long-standing health inequities, with socio-economic factors driving 50% of health outcomes. Low income's domino effect worsens health outcomes for vulnerable individuals, including hindrances to accessing virtual care. Addressing this, the study advocates for evidence-based policies, among other recommendations that are rooted in equity. Presented by: Ishaw Sharma is an Indo-Canadian healthcare professional residing in Toronto with over a decade of experience in clinical research, public health, and digital health. With a background encompassing a BSc in Life Sciences and an MBA, her commitment extends to shaping an inclusive digital healthcare system in Ontario and beyond. Ishaw also dedicates herself to advancing her academic research on current digital health and its implications on pre-existing health disparities in Ontario for racialized population. She actively advocates for equitable policies through public forums and documentary photography.